日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study

口服布鲁顿酪氨酸激酶抑制剂利扎替尼治疗免疫性血小板减少症患者的疗效和安全性结果:II期B部分研究

Cooper, Nichola; Jansen, A J Gerard; Bird, Robert; Mayer, Jiří; Sholzberg, Michelle; Tarantino, Michael D; Garg, Mamta; Ypma, Paula F; McDonald, Vickie; Percy, Charles; Košťál, Milan; Goncalves, Isaac; Bogdanov, Lachezar H; Gernsheimer, Terry B; Diab, Remco; Yao, Mengjie; Daak, Ahmed; Kuter, David J

Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United States

免疫性血小板减少症 (ITP) 患者调查:识别居住在美国的患者在治疗和疾病控制方面未满足的需求

Cooper, Nichola; Kruse, Caroline; Deneen Morgan, Sharon; Laurent, Julie; Arvelo-Saillant, Marleni; Roussy, Jean-Pascal; Cordoba, Matias; Gouia, Imene; Schmitt, Lisa-Anne; Reineke, Erin; Gernsheimer, Terry

Myoglobin saturation as an intracellular indicator for transfusion need in oncology patients

肌红蛋白饱和度作为肿瘤患者输血需求的细胞内指标

Schenkman, Kenneth A; Ciesielski, Wayne A; Gernsheimer, Terry B; Arakaki, Lorilee S L

RBCs regulate platelet function and hemostasis under shear conditions through biophysical and biochemical means

红细胞通过生物物理和生物化学手段在剪切力条件下调节血小板功能和止血。

Jiang, Debbie; Houck, Katie L; Murdiyarso, Lydia; Higgins, Harrison; Rhoads, Nicole; Romero, Sophia K; Kozar, Rosemary; Nascimbene, Angelo; Gernsheimer, Terry B; Sanchez, Zyrina Alura C; Ramasubramanian, Anand K; Adili, Reheman; Dong, Jing-Fei

Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia

利扎替尼治疗免疫性血小板减少症患者的长期疗效

Kuter, David J; Mayer, Jiri; Efraim, Merlin; Bogdanov, Lachezar H; Baker, Ross; Kaplan, Zane; Garg, Mamta; Trněný, Marek; Choi, Philip Y; Jansen, A J Gerard; McDonald, Vickie; Bird, Robert; Gumulec, Jaromir; Kostal, Milan; Gernsheimer, Terry; Ghanima, Waleed; Daak, Ahmed; Cooper, Nichola

Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients

累积供体特异性抗体阈值可预测HLA同种免疫患者的血小板输注反应

Boothby, Aaron B; Tanner, Matthew K; Alswied, Abdullah; Youngs, Danny; Bribiesca Rodriguez, Josefine; Bikkani, Thejaswi; Cha, Nuri; Gernsheimer, Terry; Gimferrer, Idoia; Hess, John R; Sokol-Hessner, Lauge; Marivada, Snigdha; Nash, Michael G; Flegel, Willy A; Vassallo, Ralph R; Stroncek, David F; Tsang, Hamilton C; Panch, Sandhya R

Fewer severe infections with tranexamic acid in patients with hematologic malignancies

血液系统恶性肿瘤患者使用氨甲环酸治疗后,严重感染发生率降低

Poston, Jacqueline N; Brown, Siobhan P; Ilich, Anton; Ginsburg, Amy Sarah; Herren, Heather; El Kassar, Nahed; Jensen, Christopher E; Triulzi, Darrell J; Key, Nigel S; May, Susanne; Gernsheimer, Terry B

Evaluating the prevalence of inborn errors of immunity in adults with chronic immune thrombocytopenia or Evans syndrome

评估患有慢性免疫性血小板减少症或埃文斯综合征的成年人中先天性免疫缺陷的患病率

Jiang, Debbie; Rosenlind, Kira; Baxter, Sarah; Gernsheimer, Terry; Gulsuner, Suleyman; Allenspach, Eric J; Keel, Siobán B

Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia

免疫性血小板减少症患者从艾曲波帕或罗米司亭换用阿伐曲波帕后血小板反应的持久性

Al-Samkari, Hanny; Jiang, Debbie; Gernsheimer, Terry; Liebman, Howard; Lee, Susie; Bernheisel, Chelsea; Wojdyla, Matthew; Vredenburg, Michael; Cuker, Adam

Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study

利扎替尼与安慰剂治疗成人和青少年持续性或慢性免疫性血小板减少症:LUNA 3 III期研究

Kuter, David J; Bussel, James B; Ghanima, Waleed; Cooper, Nichola; Gernsheimer, Terry; Lambert, Michele P; Liebman, Howard A; Tarantino, Michael D; Lee, Michelle; Guo, Hailing; Daak, Ahmed